These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32673357)

  • 21. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria.
    Sada-Ovalle I; Chiba A; Gonzales A; Brenner MB; Behar SM
    PLoS Pathog; 2008 Dec; 4(12):e1000239. PubMed ID: 19079582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of immunogenicity and vaccine efficacy between heat-shock proteins, HSP70 and GrpE, in the DnaK operon of Mycobacterium tuberculosis.
    Kim WS; Kim JS; Kim HM; Kwon KW; Eum SY; Shin SJ
    Sci Rep; 2018 Sep; 8(1):14411. PubMed ID: 30258084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection.
    Sukumar N; Tan S; Aldridge BB; Russell DG
    PLoS Pathog; 2014 Sep; 10(9):e1004394. PubMed ID: 25233380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harnessing local and systemic immunity for vaccines against tuberculosis.
    Beverley PC; Sridhar S; Lalvani A; Tchilian EZ
    Mucosal Immunol; 2014 Jan; 7(1):20-6. PubMed ID: 24253104
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Woo M; Wood C; Kwon D; Park KP; Fejer G; Delorme V
    Front Immunol; 2018; 9():438. PubMed ID: 29593716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis.
    Bertholet S; Ireton GC; Kahn M; Guderian J; Mohamath R; Stride N; Laughlin EM; Baldwin SL; Vedvick TS; Coler RN; Reed SG
    J Immunol; 2008 Dec; 181(11):7948-57. PubMed ID: 19017986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the humoral immune response and cross reactivity against Mycobacterium tuberculosis of mice immunized with liposomes containing glycolipids of Mycobacterium smegmatis.
    Borrero R; García Mde L; Canet L; Zayas C; Reyes F; Prieto JL; Infante JF; Lanio ME; Kadir R; López Y; Sarmiento ME; Nor Norazmi M; Acosta A
    BMC Immunol; 2013; 14 Suppl 1(Suppl 1):S13. PubMed ID: 23458474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination.
    Cohen SB; Gern BH; Delahaye JL; Adams KN; Plumlee CR; Winkler JK; Sherman DR; Gerner MY; Urdahl KB
    Cell Host Microbe; 2018 Sep; 24(3):439-446.e4. PubMed ID: 30146391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.
    Commandeur S; van den Eeden SJ; Dijkman K; Clark SO; van Meijgaarden KE; Wilson L; Franken KL; Williams A; Christensen D; Ottenhoff TH; Geluk A
    Vaccine; 2014 Jun; 32(29):3580-8. PubMed ID: 24837764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung.
    Woodworth JS; Cohen SB; Moguche AO; Plumlee CR; Agger EM; Urdahl KB; Andersen P
    Mucosal Immunol; 2017 Mar; 10(2):555-564. PubMed ID: 27554293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis.
    Griffiths KL; Villarreal DO; Weiner DB; Khader SA
    Hum Vaccin Immunother; 2016 Oct; 12(10):2649-2653. PubMed ID: 27322875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice.
    Chuang YM; Pinn ML; Karakousis PC; Hung CF
    Front Cell Infect Microbiol; 2018; 8():31. PubMed ID: 29473022
    [No Abstract]   [Full Text] [Related]  

  • 33. The ΔfbpA attenuated candidate vaccine from Mycobacterium tuberculosis, H37Rv primes for a stronger T-bet dependent Th1 immunity in mice.
    Roche CM; Smith A; Lindsey DR; Meher A; Schluns K; Arora A; Armitige LY; Jagannath C
    Tuberculosis (Edinb); 2011 Dec; 91 Suppl 1():S96-104. PubMed ID: 22082615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection.
    Sayes F; Pawlik A; Frigui W; Gröschel MI; Crommelynck S; Fayolle C; Cia F; Bancroft GJ; Bottai D; Leclerc C; Brosch R; Majlessi L
    PLoS Pathog; 2016 Jul; 12(7):e1005770. PubMed ID: 27467705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Profile of T Cell Responses in Bacille Calmette-Guérin-Primed Mice Boosted by a Novel Sendai Virus Vectored Anti-Tuberculosis Vaccine.
    Hu Z; Gu L; Li CL; Shu T; Lowrie DB; Fan XY
    Front Immunol; 2018; 9():1796. PubMed ID: 30123219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines.
    Romano M; Aryan E; Korf H; Bruffaerts N; Franken CL; Ottenhoff TH; Huygen K
    Microbes Infect; 2012 Jan; 14(1):86-95. PubMed ID: 21920450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomes carrying mycobacterial antigens can protect mice against Mycobacterium tuberculosis infection.
    Cheng Y; Schorey JS
    Eur J Immunol; 2013 Dec; 43(12):3279-90. PubMed ID: 23943377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice.
    Li W; Deng G; Li M; Zeng J; Zhao L; Liu X; Wang Y
    Mol Immunol; 2014 Nov; 62(1):86-95. PubMed ID: 24980867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host resistance to pulmonary Mycobacterium tuberculosis infection requires CD153 expression.
    Sallin MA; Kauffman KD; Riou C; Du Bruyn E; Foreman TW; Sakai S; Hoft SG; Myers TG; Gardina PJ; Sher A; Moore R; Wilder-Kofie T; Moore IN; Sette A; Lindestam Arlehamn CS; Wilkinson RJ; Barber DL
    Nat Microbiol; 2018 Nov; 3(11):1198-1205. PubMed ID: 30202016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactic acid bacteria enhance autophagic ability of mononuclear phagocytes by increasing Th1 autophagy-promoting cytokine (IFN-gamma) and nitric oxide (NO) levels and reducing Th2 autophagy-restraining cytokines (IL-4 and IL-13) in response to Mycobacterium tuberculosis antigen.
    Ghadimi D; de Vrese M; Heller KJ; Schrezenmeir J
    Int Immunopharmacol; 2010 Jun; 10(6):694-706. PubMed ID: 20381647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.